Evidence review
Formulary Exclusion or Step Therapy on a GLP-1: What to Do Next
An exclusion and a step therapy rule look identical on a rejection slip and need opposite responses. How to tell them apart and what to file.
On this page
The short answer
Two very different problems produce the same message at the pharmacy counter, and they need opposite responses. A formulary exclusion means the plan does not list the drug at all; the route is a formulary exception request. Utilization management — prior authorization, step therapy, quantity limits — means the drug is listed but gated; the route is meeting the criteria, or requesting an exception to them. Filing the wrong one costs you a full cycle of the plan's clock.
They are also both common. In a national all-payer study of more than two million first attempts to fill single-source branded drug prescriptions from 2018 through September 2024, 68.0% were paid on the first attempt, 14.8% were rejected for formulary exclusion, and 17.2% were rejected for prior authorization or step therapy1.
Telling them apart
| What you see | What it usually means | What to file |
|---|---|---|
| Drug absent from the formulary PDF | Formulary exclusion | Formulary exception request |
| Drug listed with a "PA" flag | Prior authorization | Criteria packet from your clinician |
| Drug listed with an "ST" flag | Step therapy | Documented history of the required alternative, or an exception request |
| Drug listed with a "QL" flag | Quantity limit | Quantity limit exception, usually a one-page form |
| Denial says the benefit category is excluded | Plan design, not the drug list | Ask for the plan document language, then price the cash lane |
That last row is the one people misread for weeks. A plan can list every GLP-1 on its formulary and separately exclude anti-obesity medication as a benefit. The drug list says yes and the benefit says no, and no amount of clinical documentation changes a benefit that was never bought.
The calendar is the real cost
Step therapy is described as a sequence, so it reads like an inconvenience. For a working mother it is a scheduling problem: each step consumes an appointment, a fill, and a documented trial period before the next one can begin.
The measured cost of a single bounce is not small. In the same national study, among people whose initial fill was rejected, 38.6% ultimately received the rejected molecule within 90 days and 48.4% received nothing in the same therapeutic class within that window. Among those who eventually got the molecule or a substitute, treatment initiation was delayed by an average of 12.2 days1.
So plan the paperwork the way you would plan childcare: in parallel, not in sequence. Ask your clinician to submit the criteria packet on the same day the prescription is written, and ask the pharmacy to run a test claim rather than waiting to discover the rejection at pickup.
Why the state law you read about may not apply to you
Search this topic and you will find articles about state step-therapy override laws. Many are real. Most probably do not reach your plan.
Under ERISA, federal law supersedes state laws insofar as they relate to an employee benefit plan, and while nothing exempts anyone from a state law that regulates insurance, an employee benefit plan may not be deemed to be an insurance company or other insurer for the purposes of any state law purporting to regulate insurance companies or insurance contracts2. That deemer clause is why a self-funded employer plan generally sits outside state insurance mandates — and 67% of covered workers, including 80% at firms with 200 or more workers, are in self-funded plans3.
Practical version: before you cite a state protection in a letter, confirm your plan is insured rather than self-funded. Your Summary Plan Description names who pays the claims. If it says the employer's general assets or a plan trust, the state rule is probably not your lever, and the federal claims-procedure rights are.
What you do have, on every employer plan
- The criteria in writing. Ask for the prior authorization criteria document and the internal rule or guideline relied upon in any denial.
- A minimum of 180 days to file an internal appeal after you receive an adverse determination4.
- A decision clock. A pre-service claim must be decided within 15 days, extendable once by 15; an appeal of a pre-service claim within 30 days on a one-level plan, or 15 days per level on a two-level plan4.
- An exception process. Even an excluded drug usually has one. It is a different form from an appeal, and asking for it by name gets you the right one.
- External review afterwards, if the internal appeals fail.
Choosing between the fight and the cash lane
Both are legitimate, and the honest comparison is a calendar comparison as much as a money one. If your plan lists the drug and gates it, the fight is usually worth one round — the criteria are knowable and the documentation is a single appointment. If the benefit category is excluded outright, treat that as settled for the plan year and price the alternative.
Work the numbers with insurance vs cash-pay: the real monthly math, then use our cheapest GLP-1 board for the shortlist and how to get a GLP-1 without insurance for the full cash playbook. If you are still gathering documents, the appeal letter templates give you the paragraph for each denial reason, and who decides whether your plan pays explains where the formulary comes from in the first place.
The decisive takeaway
Read the rejection before you write anything: an exclusion needs an exception request, a step therapy flag needs documented history, and a benefit-category carve-out needs a different plan or a cash program. Confirm whether your plan is self-funded before you rely on a state rule, submit the criteria packet the same day the prescription is written, and count the delay in weeks rather than in forms. Some links here earn us a referral fee, which never changes the ranking.
Frequently asked questions
What is the difference between a formulary exclusion and step therapy?
A formulary exclusion means the drug is not on your plan's list at all, and the route is a formulary exception request. Step therapy means the drug is on the list but the plan requires you to try a different medication first; the route is documenting that you already tried it, or that it is contraindicated, and requesting an exception. Filing the wrong request restarts the plan's clock.
Do state step therapy override laws apply to my employer plan?
Often not. ERISA supersedes state laws that relate to an employee benefit plan, and a plan may not be deemed an insurance company for purposes of state laws regulating insurers. That generally places self-funded employer plans outside state insurance mandates, and 67% of covered workers are in self-funded plans. Check whether your plan is insured or self-funded before relying on a state protection.
How much time does a rejected first fill actually cost?
In a national all-payer study, among initial fill attempts that were rejected, 38.6% resulted in the same molecule being dispensed within 90 days while 48.4% resulted in no fill in the same therapeutic class at all. For those who did eventually start, treatment initiation was delayed by an average of 12.2 days.
Where this leaves you
References
- Levy JF, Alexander GC, Vabson B, Ippolito BN (2026). Formulary-Related Insurance Denials of Single-Source Branded Drugs in the United States. JAMA. https://pubmed.ncbi.nlm.nih.gov/42424046/
- United States Code (2026). 29 U.S.C. 1144 — Other laws (ERISA preemption, savings and deemer clauses). Office of the Law Revision Counsel, U.S. House of Representatives. https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title29-section1144&num=0&edition=prelim
- KFF (Kaiser Family Foundation) (2025). Employer Health Benefits Survey — 2025 Annual Survey, Summary of Findings. KFF. https://files.kff.org/attachment/Employer-Health-Benefits-Survey-2025-Annual-Survey-Summary-of-Findings.pdf
- U.S. Department of Labor, Employee Benefits Security Administration (2026). 29 CFR 2560.503-1 — Claims procedure. Electronic Code of Federal Regulations. https://www.ecfr.gov/current/title-29/subtitle-B/chapter-XXV/subchapter-G/part-2560/section-2560.503-1
Read this as information, not instructions. WorkingMomRx is educational and never a diagnosis, a treatment plan, or a reason to start or stop a medication. A GLP-1 is a clinical decision — run it past a licensed clinician who knows your history before you act on anything here.
Continue reading
Superbills for Telehealth GLP-1 Care: How to Claim Money Back
You paid cash for a telehealth GLP-1 visit. What a superbill must contain, where to send it, and what actually gets reimbursed.
ReadGLP-1 Denial Appeal Letters: Templates by Reason for Denial
Copy-and-send appeal paragraphs for the five most common GLP-1 denial reasons, plus the federal deadlines that govern your appeal.
ReadThe Letter of Medical Necessity Your FSA Administrator Wants
Why FSA and HSA claims for a GLP-1 get rejected, exactly what the letter must say, and a draft to hand your prescriber.
Read